New Jersey Keeps Newborn DNA for 23 Years. Parents Are Suing
By Emily Mullin,
Wired
| 11. 08. 2023
When Hannah Lovaglio’s children were born, she didn’t think twice about the newborn health screening they received in the hospital. The routine test uses a few drops of blood from a heel prick to test for dozens of potentially fatal or disabling genetic diseases.
“I assumed that this was for my child’s best interest and for the best interest of public health,” says Lovaglio, a pastor in New Jersey. What she didn’t know was that after testing was completed, the leftover blood would be stored by the state for 23 years and could be used for purposes beyond medical testing. In a court case that became public last year, New Jersey police allegedly used a baby’s blood sample to investigate its father for a crime.
Lovaglio has joined a federal class action against the New Jersey Department of Health and its Division of Family Health Services, which oversees the state’s newborn testing program. She and the other plaintiffs are suing the state over its storage practices. They argue that parents aren’t told how long the samples are kept, or...
Related Articles
By GMWatch Contributors, GMWatch | 11.21.2023
Open letter to UK's FSA is published
A group of experts representing business, farming, certification, academia, science and civil society have lodged a formal complaint against the UK’s Food Standards Agency (FSA), raising serious concerns about its public consultation process...
By Helen Floersh, Fierce Biotech | 11.10.2023
The images are unsettling, to put it mildly: a baby monkey whose skin grows eerily green, with glowing fingertips reminiscent of E.T.
This is “#10,” the world’s first live-born monkey that’s largely made up of embryonic stem cells, or ESCs...
By Quinton Amundson, The Catholic Register | 11.10.2023
With danger comes some interesting prospects in the field of gene therapy and genome editing, Dr. Brett Salkeld believes.
It’s something the archdiocesan theologian for Regina will examine with a Nov. 15 presentation at Newman Theological College in Edmonton.
Salkeld’s...
By Derrick Gingery, Pink Sheet | 11.01.2023
Some worries about heritable genetic modifications are subsiding and Center for Biologics Evaluation and Research Director Peter Marks said sponsors should consider the US for regulatory advice and clinical trials in the space.
The US Food and Drug Administration’s growing...